Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-117.65	-75.46	-34.67
Graham Fair Price	256.28	4.47	1.25
PEG	-99.51	< 0.005	0.97
Price/Book	-14.90	0.17	0.20
Price/Cash Flow	34.11	-86.20	-130.82
Prices/Earnings	93.44	-5.54	-84.42
Price/Sales	18.08	2.35	1.99
Price/FCF	34.11	-86.20	-130.82
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-99.86	< 0.005	0.13
Operating Margin	133.32	-0.13	0.05
ROA	-1210.13	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-1197.68
ROIC	< 0.005	-0.01	-1919.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.09	-0.02	-352.54
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	23.89	-2.67	-88.83
EPS QOQ	0.87	-11.77	1249.61
FCF QOQ	-1.05	-0.28	73.11
Revenue QOQ	0.06	-0.28	356.14
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	36.74	44.58	21.34
Days Sales Outstanding (DSO)	27.10	67.54	149.27
Inventory Turnover	2.45	2.02	-17.58
Debt/Capitalization	0.10	0.09	-7.56
Quick Ratio	4.47	4.55	1.77
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.81	10.69	-1.10
Cash	6.03	5.89	-2.41
Capex	-0.20	0.00	inf
Free Cash Flow	-0.02	-0.02	-27.74
Revenue	1.10	0.78	-28.72
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.92	4.82	-2.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-64.28	-123.99	-92.91
Naive Interpretation	Member

06 - Financial Health · Bad

Rating